{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:52:22Z","timestamp":1791240742372,"version":"4.1.0"},"reference-count":253,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00671-5","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:15:49Z","timestamp":1791177349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging nanostructured platforms for improved oral delivery of antidiabetic agents: overcoming physiological barriers and enhancing therapeutic efficacy"],"prefix":"10.1007","volume":"34","author":[{"given":"Shweta","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4356-3423","authenticated-orcid":false,"given":"Madhusudan","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-2397","authenticated-orcid":false,"given":"Shobha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"2","key":"671_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2026","unstructured":"Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S, Thirunavukkarasu S, Issaka A, Chen L, Basit A, Luk AOY, Ma RCW, Mbanya J-C, Ramachandran A, Wild SH, Duncan BB, Boyko EJ, Magliano DJ. 11th edition of the IDF Diabetes Atlas: Global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14(2):149\u201356. https:\/\/doi.org\/10.1016\/S2213-8587(25)00299-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"671_CR2","unstructured":"DJ, EJ, editors. IDF Diabetes Atlas. 11th ed. International Diabetes Federation; 2025. https:\/\/diabetesatlas.org."},{"key":"671_CR3","unstructured":"International Diabetes Federation. Diabetes facts & figures. International Diabetes Federation; 2025. https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/."},{"key":"671_CR4","unstructured":"International Diabetes Federation. (2025, April 7). Over 250 million people worldwide unaware they have diabetes, according to new IDF research. https:\/\/idf.org\/news-and-resources\/news\/idf-diabetes-atlas-11th-edition\/"},{"issue":"3","key":"671_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2337\/dc25-2583","volume":"49","author":"F Teufel","year":"2026","unstructured":"Teufel F, Orgutsova K, Genitsaridi I, Carrillo-Larco RM, Varghese JS, Marcus ME, Sacre JW, Sajjadi SF, Chiwanga F, Manne-Goehler J, Seiglie J, Flood D, Harding J, Salpea P, Salim A, Boyko EJ, Magliano DJ, Ali MK. Global, regional, and national estimates of undiagnosed diabetes in adults: Findings from the 2025 IDF Diabetes Atlas. Diabetes Care. 2026;49(3):490\u20136. https:\/\/doi.org\/10.2337\/dc25-2583.","journal-title":"Diabetes Care"},{"key":"671_CR6","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. Standards of care in diabetes\u20142025. Diabetes Care. 2025;48(Supplement1). https:\/\/doi.org\/10.2337\/dc25-SINT.","DOI":"10.2337\/dc25-SINT"},{"key":"671_CR7","unstructured":"Sinko PJ, Martin AN. Martin\u2019s physical pharmacy and pharmaceutical sciences. 8th ed. Wolters Kluwer; 2025."},{"key":"671_CR8","unstructured":"Florence AT, Siepmann J. Modern pharmaceutics. 6th ed. CRC; 2025."},{"key":"671_CR9","unstructured":"Torchilin VP. Nanoparticulate drug delivery systems: Design, development, and clinical translation. Springer; 2025."},{"key":"671_CR10","doi-asserted-by":"publisher","first-page":"115282","DOI":"10.1016\/j.addr.2025.115282","volume":"218","author":"R Singh","year":"2025","unstructured":"Singh R, Lillard JW, Banerjee A. Advances in oral nanomedicine for peptide and protein delivery. Adv Drug Deliv Rev. 2025;218:115282. https:\/\/doi.org\/10.1016\/j.addr.2025.115282.","journal-title":"Adv Drug Deliv Rev"},{"key":"671_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jconrel.2025.01.018","volume":"381","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang X, Liu H, Chen J, Li W. Nanotechnology-enabled oral delivery systems for antidiabetic therapeutics: Current progress and future perspectives. J Controlled Release. 2025;381:470\u201392. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.018.","journal-title":"J Controlled Release"},{"issue":"1","key":"671_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11033-025-11389-z","volume":"53","author":"ZA Wani","year":"2025","unstructured":"Wani ZA, Sharma AK, Muzamil S, Mir MN, Malik IA, Naik RA, Malik SS, Badroo IA, Hurra AR, Lone Y. Molecular pathways of oxidative stress in diabetes: redox imbalance and insulin pathway dysregulation. Mol Biol Rep. 2025;53(1):222. https:\/\/doi.org\/10.1007\/s11033-025-11389-z.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"671_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11033-025-11389-z","volume":"53","author":"ZA Wani","year":"2025","unstructured":"Wani ZA, Sharma AK, Muzamil S, Mir MN, Malik IA, Naik RA, Malik SS, Badroo IA, Hurra AR, Lone Y. Molecular pathways of oxidative stress in diabetes: redox imbalance and insulin pathway dysregulation. Mol Biol Rep. 2025;53(1):222. https:\/\/doi.org\/10.1007\/s11033-025-11389-z.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"671_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11033-025-11389-z","volume":"53","author":"ZA Wani","year":"2025","unstructured":"Wani ZA, Sharma AK, Muzamil S, Mir MN, Malik IA, Naik RA, Malik SS, Badroo IA, Hurra AR, Lone Y. Molecular pathways of oxidative stress in diabetes: redox imbalance and insulin pathway dysregulation. Mol Biol Rep. 2025;53(1):222. https:\/\/doi.org\/10.1007\/s11033-025-11389-z.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"671_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/CM9.0000000000003230","volume":"138","author":"X Chen","year":"2025","unstructured":"Chen X, Xie N, Feng L, Huang Y, Wu Y, Zhu H, Tang J, Zhang Y. Oxidative stress in diabetes mellitus and its complications: From pathophysiology to therapeutic strategies. Chin Med J. 2025;138(1):15\u201327. https:\/\/doi.org\/10.1097\/CM9.0000000000003230.","journal-title":"Chin Med J"},{"issue":"1 Suppl 1","key":"671_CR16","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S181\u2013206. https:\/\/doi.org\/10.2337\/dc25-S009.","journal-title":"Diabetes Care"},{"key":"671_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","volume":"24","author":"DJ Drucker","year":"2025","unstructured":"Drucker DJ. GLP-1-based therapies for diabetes, obesity and beyond. Nat Rev Drug Discovery. 2025;24:631\u201350. https:\/\/doi.org\/10.1038\/s41573-025-01183-8.","journal-title":"Nat Rev Drug Discovery"},{"key":"671_CR18","doi-asserted-by":"publisher","unstructured":"White JR Jr, Neumiller JJ, editors. 2025\u201326 Guide to Medications for the Treatment of Diabetes Mellitus. American Diabetes Association; 2025. https:\/\/doi.org\/10.2337\/9781580408462.","DOI":"10.2337\/9781580408462"},{"issue":"9","key":"671_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41575-025-01092-6","volume":"22","author":"JE Brinck","year":"2025","unstructured":"Brinck JE, Sinha AK, Laursen MF, Dragsted LO, Raes J, Walter J, Roager HM, Licht TR. Intestinal pH: A major driver of human gut microbiota composition and metabolism. Nat Reviews Gastroenterol Hepatol. 2025;22(9):639\u201356. https:\/\/doi.org\/10.1038\/s41575-025-01092-6.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"4","key":"671_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/pharmaceutics17040397","volume":"17","author":"KC Baral","year":"2025","unstructured":"Baral KC, Choi KY. Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances. Pharmaceutics. 2025;17(4):397. https:\/\/doi.org\/10.3390\/pharmaceutics17040397.","journal-title":"Pharmaceutics"},{"issue":"4","key":"671_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/pharmaceutics17040397","volume":"17","author":"KC Baral","year":"2025","unstructured":"Baral KC, Choi KY. Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances. Pharmaceutics. 2025;17(4):397. https:\/\/doi.org\/10.3390\/pharmaceutics17040397.","journal-title":"Pharmaceutics"},{"key":"671_CR22","doi-asserted-by":"publisher","first-page":"102763","DOI":"10.1016\/j.mtbio.2026.102763","volume":"37","author":"X Wang","year":"2026","unstructured":"Wang X, Wang K, Fang Y, Zhang Y, Yi L, Li X, Zhao Q, Zhu X, Cai S, Wan L. Strategies for overcoming multiple barriers of oral administration of protein and peptide therapeutics. Mater today Bio. 2026;37:102763. https:\/\/doi.org\/10.1016\/j.mtbio.2026.102763.","journal-title":"Mater today Bio"},{"issue":"4","key":"671_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/pharmaceutics17040397","volume":"17","author":"KC Baral","year":"2025","unstructured":"Baral KC, Choi KY. Barriers and strategies for oral peptide and protein therapeutics delivery: Update on clinical advances. Pharmaceutics. 2025;17(4):397. https:\/\/doi.org\/10.3390\/pharmaceutics17040397.","journal-title":"Pharmaceutics"},{"issue":"7","key":"671_CR24","doi-asserted-by":"publisher","first-page":"rgag078","DOI":"10.1093\/jpp\/rgag078","volume":"78","author":"HF Chang","year":"2026","unstructured":"Chang HF, Lin TM, Sun YL, Lin TC, Lin CS. The latest developments in oral insulin: scientific advances and clinical progress. J Pharm Pharmacol. 2026;78(7):rgag078.","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"671_CR25","doi-asserted-by":"publisher","first-page":"e70275","DOI":"10.1111\/1541-4337.70275","volume":"24","author":"M Yu","year":"2025","unstructured":"Yu M, Chi C, Chen L, Li X. Tailoring Smart Oral Nano\/Micro Delivery System to Address Multifaceted Gastrointestinal Barriers for Improved Delivery of Food Bioactive Compounds. Compr Rev Food Sci Food Saf. 2025;24(5):e70275. https:\/\/doi.org\/10.1111\/1541-4337.70275.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"#cr-split#-671_CR26.1","doi-asserted-by":"crossref","unstructured":"Baral KC, Choi KY. (2026). Correction: Baral, KC","DOI":"10.1155\/crid\/1622928"},{"key":"#cr-split#-671_CR26.2","doi-asserted-by":"crossref","unstructured":"Choi, KY Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances. Pharmaceutics 2025, 17, 397. Pharmaceutics, 18(7), 864.","DOI":"10.3390\/pharmaceutics18070864"},{"key":"671_CR27","doi-asserted-by":"publisher","first-page":"1776167","DOI":"10.3389\/fddev.2026.1776167","volume":"6","author":"SK Niazi","year":"2026","unstructured":"Niazi SK. Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage. Front Drug Delivery. 2026;6:1776167.","journal-title":"Front Drug Delivery"},{"issue":"1","key":"671_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10930-025-10302-8","volume":"45","author":"M Cheshomi","year":"2026","unstructured":"Cheshomi M, Shobeiri N, Tajani AS, Khameneh B. Strategic approaches for overcoming peptide and protein drug limitations. Protein J. 2026;45(1):8\u201321.","journal-title":"Protein J"},{"key":"671_CR29","doi-asserted-by":"publisher","first-page":"1809842","DOI":"10.3389\/fddev.2026.1809842","volume":"6","author":"NUA Khalid","year":"2026","unstructured":"Khalid NUA, Rivera-Delgado E, von Erlach T. Navigating the complexity of oral peptide delivery: challenges and strategies to enhance oral bioavailability. Front Drug Delivery. 2026;6:1809842.","journal-title":"Front Drug Delivery"},{"issue":"5","key":"671_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.5281\/zenodo.19997565","volume":"5","author":"SS .Pawar","year":"2026","unstructured":"Pawar SS, Bachhav IC, Panda NA, Bhoi LB, Ahire BB, Patil NM, Chavan GM. Pharmacological challenges and advances in controlled release delivery of peptide therapeutics. World J Pharm Sci Res. 2026;5(5):539\u201365. https:\/\/doi.org\/10.5281\/zenodo.19997565.","journal-title":"World J Pharm Sci Res"},{"key":"671_CR31","doi-asserted-by":"crossref","unstructured":"Rabbani, S. A., Saini, M., El-Tanani, M., Kumar, R., Matalka, I., El-Tanani, Y., \u2026Rizzo, M. (2026). Oral GLP-1-Based Therapeutics in the Obesity\u2013Metabolic Syndrome\u2013Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies. Pharmaceuticals, 19(5), 732.","DOI":"10.3390\/ph19050732"},{"key":"671_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.72.e140734","volume":"72","author":"F Darusman","year":"2025","unstructured":"Darusman F, Rusdiana T, Sopyan I, Rahma H, Hanifa M. Recent progress in pharmaceutical excipients as P-glycoprotein inhibitors for potential improvement of oral drug bioavailability: A comprehensive overview. Pharmacia. 2025;72:1\u201316. https:\/\/doi.org\/10.3897\/pharmacia.72.e140734.","journal-title":"Pharmacia"},{"issue":"3","key":"671_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/ph19030454","volume":"19","author":"DK Vo","year":"2026","unstructured":"Vo DK, Duong VA. Biomarker-Guided Drug Delivery Systems and Oral Bioavailability Enhancement. Pharmaceuticals. 2026;19(3):454.","journal-title":"Pharmaceuticals"},{"key":"671_CR34","doi-asserted-by":"crossref","unstructured":"Umutoni, S., Zhang, H., Guo, J., Yu, Z., Shao, H., Yi, X., \u2026 Yu, Y. (2026). Oral anticancer drug delivery: Strategies for improving bioavailability. Chinese Chemical Letters, 112362.","DOI":"10.1016\/j.cclet.2026.112362"},{"key":"671_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2026.01.030","author":"Y Zheng","year":"2026","unstructured":"Zheng Y, Chen B, Huang X, Ai C, Teng H, Chen L. Boosting luteolin bioavailability via P-glycoprotein efflux inhibition: a self-microemulsifying drug delivery systems. J Adv Res. 2026. https:\/\/doi.org\/10.1016\/j.jare.2026.01.030.","journal-title":"J Adv Res"},{"key":"671_CR36","doi-asserted-by":"publisher","first-page":"108135","DOI":"10.1016\/j.jddst.2026.108135","volume":"119","author":"J Yoo","year":"2026","unstructured":"Yoo J, Kim D, You EH, Park S, Park J-B, Park C, Lee B-J. Development and bioavailability modulation of once-daily controlled release apixaban tablets by utilizing functional pharmaceutical excipients. J Drug Deliv Sci Technol. 2026;119:108135. https:\/\/doi.org\/10.1016\/j.jddst.2026.108135.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"671_CR37","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s44174-025-00442-x","volume":"4","author":"MV Kodli","year":"2026","unstructured":"Kodli MV, Raikar PK, Kulkarni P, Kulkarni U, Ahmed KA. Strategies to enhance the bioavailability of hydrophilic drugs using natural bioenhancers. Biomedical Mater Devices. 2026;4(3):3067\u201388.","journal-title":"Biomedical Mater Devices"},{"key":"671_CR38","first-page":"97","volume":"2025","author":"CM Hossain","year":"2026","unstructured":"Hossain CM, Choudhuri S, Das R, Saha S, Banerjee A. Lipid-Based Oral Formulation Strategies for Enhancing Bioavailability of Aromatase. Pharmacol Annual 2025. 2026;2025:97.","journal-title":"Pharmacol Annual 2025"},{"key":"671_CR39","doi-asserted-by":"publisher","unstructured":"Jain H, Aggarwal NK. Bioavailability and pharmacokinetics of plant metabolites in neurotherapeutics. In Jain M, Tariq M, Mohammed A, Madan A, editors. Plant-derived neurotherapeutics: Mechanisms and applications for brain health. Scrivener Publishing\/Wiley; 2026. pp. 391\u2013434. https:\/\/doi.org\/10.1002\/9781394360260.ch12.","DOI":"10.1002\/9781394360260.ch12"},{"issue":"06","key":"671_CR40","first-page":"372","volume":"2","author":"G Rao","year":"2026","unstructured":"Rao G, Kumar A, Shah A. Formulation and Performance Evaluation of Gallopamil-Loaded Oral Disintegrating Films: Role of Polymer Composition in Drug Delivery. Int J Med Pharm Sci. 2026;2(06):372\u201383.","journal-title":"Int J Med Pharm Sci"},{"issue":"06","key":"671_CR41","first-page":"372","volume":"2","author":"G Rao","year":"2026","unstructured":"Rao G, Kumar A, Shah A. Formulation and Performance Evaluation of Gallopamil-Loaded Oral Disintegrating Films: Role of Polymer Composition in Drug Delivery. Int J Med Pharm Sci. 2026;2(06):372\u201383.","journal-title":"Int J Med Pharm Sci"},{"key":"671_CR42","doi-asserted-by":"crossref","unstructured":"Liu X, Xie L, Chen W. Machine-Learning-Driven Optimization of Functional Excipients and Their Biointeractions in Drug Formulations. ACS Pharmacology & Translational Science; 2026.","DOI":"10.1021\/acsptsci.6c00322"},{"issue":"5","key":"671_CR43","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1080\/10837450.2026.2674731","volume":"31","author":"EM El Hathout","year":"2026","unstructured":"Hathout EM, Eltokhy SS, Abdelkader DH, El Maghraby GM. Capryol-ethyl oleate self-microemulsifying system for improved intestinal absorption and hypoglycemic activity of empagliflozin. Pharm Dev Technol. 2026;31(5):778\u201393. https:\/\/doi.org\/10.1080\/10837450.2026.2674731.","journal-title":"Pharm Dev Technol"},{"issue":"4","key":"671_CR44","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/02726351.2026.2626925","volume":"44","author":"HS Mahajan","year":"2026","unstructured":"Mahajan HS, Patil PH, Patil DD, Ninave PB, Nerkar PP. Tocofersolan micelles for improved solubility and oral bioavailability of ritonavir. Part Sci Technol. 2026;44(4):680\u201391.","journal-title":"Part Sci Technol"},{"key":"671_CR45","doi-asserted-by":"crossref","unstructured":"Kumar R, Singh A, Alam S. Nanoemulsions for Targeted Brain Drug Delivery via the Olfactory Pathway: Recent Advances and Perspectives. Drug Delivery Letters; 2026.","DOI":"10.2174\/0122103031401403251204131734"},{"issue":"15","key":"671_CR46","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3390\/molecules31152567","volume":"31","author":"K Lu","year":"2026","unstructured":"Lu K, Wang C, Li J. Spinosin: A Critical Updated Review on Pharmacology, Pharmacokinetics, Toxicity and Translational Bottlenecks. Molecules. 2026;31(15):2567.","journal-title":"Molecules"},{"issue":"Supplement1","key":"671_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/nutrit\/nuaf248","volume":"84","author":"M Luo","year":"2026","unstructured":"Luo M, Xiao H. Black Pepper and Dietary Lipids Synergistically Enhance Carotenoid Bioavailability: A Narrative Review. Nutr Rev. 2026;84(Supplement1):81\u20138.","journal-title":"Nutr Rev"},{"key":"671_CR48","doi-asserted-by":"crossref","unstructured":"Ghaemi, N. S., Amiri, M., Moharramnejad, M., Yarahmadi, S., Nabavi, J., Kahvand, M.,\u2026 Ehsani, A. (2026). A review of recent developments of bio-polymers as combined biomedical platforms over the past decade. Polymer Bulletin, 83(10), 559.","DOI":"10.1007\/s00289-026-06613-0"},{"key":"671_CR49","doi-asserted-by":"publisher","first-page":"115167","DOI":"10.1016\/j.ejpb.2026.115167","volume":"226","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Cheng J, Wang H, Zong Z, Zhang W, Shen Y, Tian Y. Hydrophobic ion pairing formed semaglutide designed for oral self-microemulsifying delivery in diabetes treatment. Eur J Pharm Biopharm. 2026;226:115167. https:\/\/doi.org\/10.1016\/j.ejpb.2026.115167.","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"671_CR50","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1080\/03639045.2026.2675437","volume":"52","author":"RF Alzhrani","year":"2026","unstructured":"Alzhrani RF, Imam SS, Alshehri S, Mahdi WA, Fitaihi RA, Alobid S, Harisa GI. Improving Paclitaxel permeation and anticancer efficacy through Soluplus-based solid dispersion with Piperine. Drug Dev Ind Pharm. 2026;52(7):1391\u2013403.","journal-title":"Drug Dev Ind Pharm"},{"key":"671_CR51","doi-asserted-by":"publisher","DOI":"10.1039\/D6PM00150E","author":"M Nasr","year":"2026","unstructured":"Nasr M, Saber S, Youssef ME, Asad H, Kira AY. Cubosomal nanoparticles for improved edoxaban bioavailability: overcoming solubility and permeability barriers of a BCS class IV drug. RSC Pharm. 2026. https:\/\/doi.org\/10.1039\/D6PM00150E.","journal-title":"RSC Pharm"},{"key":"671_CR52","doi-asserted-by":"crossref","unstructured":"Kansara V, Mahajan Y, Vyas B, Chauhan V, Patel M. (2026). Enhanced solubility and bioavailability of zanubrutinib nanocrystals: Physicochemical and Pharmacokinetic evaluation. Pharmaceutical Development and Technology, (just-accepted), 1\u201316.","DOI":"10.1080\/10837450.2026.2696448"},{"key":"671_CR53","doi-asserted-by":"crossref","unstructured":"Sharma, P., Katyal, P., Magotra, T., Faisal, S. M., Karmbir, Yadav, S., \u2026 Sharma,A. (2026). Strategic Advances in Drug Delivery Systems for Overcoming Solubility and Permeability Barriers in Class II and IV Drugs. Current Pharmaceutical Design.","DOI":"10.2174\/0113816128416755251028072444"},{"key":"671_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44174-026-00719-9","volume":"4","author":"K Mangu","year":"2026","unstructured":"Mangu K, Nadimpalli AV, Chenna SR, Rizwanullah M. Harnessing TPGS-based nanoparticles to overcome multidrug resistance in Cancer. Biomedical Mater Devices. 2026;4:1\u201318. https:\/\/doi.org\/10.1007\/s44174-026-00719-9.","journal-title":"Biomedical Mater Devices"},{"issue":"7","key":"671_CR55","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.chom.2026.06.001","volume":"34","author":"F Guo","year":"2026","unstructured":"Guo F, Bai Y, Lei X. Gut microbiota alters drug metabolism and therapeutic outcomes. Cell Host Microbe. 2026;34(7):1262\u201372.","journal-title":"Cell Host Microbe"},{"key":"671_CR56","doi-asserted-by":"publisher","first-page":"1801422","DOI":"10.3389\/fnano.2026.1801422","volume":"8","author":"R Chauhan","year":"2026","unstructured":"Chauhan R. Advancements in polymer-and lipid-based nanoparticles for enhancing drug solubility, stability, and bioavailability: an integrative and forward-looking review. Front Nanatechnol. 2026;8:1801422.","journal-title":"Front Nanatechnol"},{"issue":"16","key":"671_CR57","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2174\/1381612824666180522092743","volume":"24","author":"S Pandey","year":"2018","unstructured":"Pandey S, Patel P, Gupta A. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology. Curr Pharm Design. 2018;24(16):1811\u201320. https:\/\/doi.org\/10.2174\/1381612824666180522092743.","journal-title":"Curr Pharm Design"},{"issue":"12","key":"671_CR58","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1080\/03639045.2021.2004265","volume":"47","author":"S Khan","year":"2021","unstructured":"Khan S, Baboota S, Ali J, Narang RS. Design expert assisted formulation, characterization and optimization of microemulsion-based solid lipid nanoparticles of repaglinide. Drug Dev Ind Pharm. 2021;47(12):1938\u201351. https:\/\/doi.org\/10.1080\/03639045.2021.2004265.","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"671_CR59","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/02652048.2025.2495290","volume":"42","author":"HA Hussein","year":"2025","unstructured":"Hussein HA, Khaphi FL, Sivaramakrishnan R, Poornima S, Abdullah MA. Recent developments in sustained-release and targeted drug delivery applications of solid lipid nanoparticles. J Microencapsul. 2025;42(5):472\u2013502. https:\/\/doi.org\/10.1080\/02652048.2025.2495290.","journal-title":"J Microencapsul"},{"key":"671_CR60","doi-asserted-by":"publisher","unstructured":"Aggarwal K, Joshi S, Jindal P, Patel P, Kurmi BD. Solid lipid nanoparticles: An innovative drug delivery system for enhanced bioavailability and targeted therapy. AAPS PharmSciTech. 2025;26(6). https:\/\/doi.org\/10.1208\/s12249-025-03185-6.","DOI":"10.1208\/s12249-025-03185-6"},{"key":"671_CR61","doi-asserted-by":"publisher","DOI":"10.2174\/0124054615360932250721110031","author":"K Kashyap","year":"2025","unstructured":"Kashyap K, Sharma A, Mittal V, Malhotra H. Nanostructured lipid carriers: A modern approach to optimizing drug delivery systems. Curr Nanomaterials. 2025. https:\/\/doi.org\/10.2174\/0124054615360932250721110031. Advance online publication.","journal-title":"Curr Nanomaterials"},{"key":"671_CR62","doi-asserted-by":"publisher","first-page":"107191","DOI":"10.1016\/j.jddst.2025.107191","volume":"111","author":"MH El Komy","year":"2025","unstructured":"El Komy MH. Determinants of oral delivery from two lipid nanocarriers: Systematic review and meta-analysis of bioavailability studies. J Drug Deliv Sci Technol. 2025;111:107191. https:\/\/doi.org\/10.1016\/j.jddst.2025.107191.","journal-title":"J Drug Deliv Sci Technol"},{"key":"671_CR63","doi-asserted-by":"publisher","DOI":"10.2174\/0124054615360932250721110031","author":"K Kashyap","year":"2025","unstructured":"Kashyap K, Sharma A, Mittal V, Malhotra H. Nanostructured lipid carriers: A modern approach to optimizing drug delivery systems. Curr Nanomaterials. 2025. https:\/\/doi.org\/10.2174\/0124054615360932250721110031. Advance online publication.","journal-title":"Curr Nanomaterials"},{"key":"671_CR64","doi-asserted-by":"publisher","first-page":"104041","DOI":"10.1016\/j.jddst.2022.104041","volume":"79","author":"S Faiz","year":"2023","unstructured":"Faiz S, Arshad S, Kamal Y, Imran S, Asim MH, Mahmood A, Inam S, Irfan HM, Riaz H. Pioglitazone-loaded nanostructured lipid carriers: In vitro and in vivo evaluation for improved bioavailability. J Drug Deliv Sci Technol. 2023;79:104041. https:\/\/doi.org\/10.1016\/j.jddst.2022.104041.","journal-title":"J Drug Deliv Sci Technol"},{"key":"671_CR65","doi-asserted-by":"publisher","first-page":"107191","DOI":"10.1016\/j.jddst.2025.107191","volume":"111","author":"MH El Komy","year":"2025","unstructured":"El Komy MH. Determinants of oral delivery from two lipid nanocarriers: Systematic review and meta-analysis of bioavailability studies. J Drug Deliv Sci Technol. 2025;111:107191. https:\/\/doi.org\/10.1016\/j.jddst.2025.107191.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"671_CR66","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2174\/0124681873314947240816094434","volume":"16","author":"V Deshmukh","year":"2026","unstructured":"Deshmukh V, Jain D. Advances in Nanoemulsion Formulation for Enhanced Drug Delivery: A Comprehensive Review. Curr Nanomed. 2026;16(1):74\u201394.","journal-title":"Curr Nanomed"},{"key":"671_CR67","doi-asserted-by":"publisher","first-page":"2630012","DOI":"10.1142\/S1793984426300128","volume":"16","author":"M Dogra","year":"2026","unstructured":"Dogra M, Kumar P, Singh B, Sharma T. Topical drug delivery using self-emulsifying nanolipidic systems: formulation design and applications. Nano LIFE. 2026;16:2630012.","journal-title":"Nano LIFE"},{"issue":"3","key":"671_CR68","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1208\/s12249-026-03398-3","volume":"27","author":"S Gawde","year":"2026","unstructured":"Gawde S, Bachhav Y, Kumar MS. Effective Brain Targeting Using the Self-Emulsifying Drug Delivery Systems. AAPS PharmSciTech. 2026;27(3):156.","journal-title":"AAPS PharmSciTech"},{"issue":"02","key":"671_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31069\/japsr.v9i2.01","volume":"9","author":"N Nagpure","year":"2026","unstructured":"Nagpure N, Dhoke V, Singh R, Gupta S, Rasala T. A Comprehensive Review on Self-Microemulsifying Drug Delivery Systems: From Design and Evaluation to Regulatory Challenges. J Appl Pharm Sci Res. 2026;9(02):1\u201321.","journal-title":"J Appl Pharm Sci Res"},{"issue":"6","key":"671_CR70","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/pharmaceutics18060637","volume":"18","author":"S Soni","year":"2026","unstructured":"Soni S, Andey T. Formulation Characteristics of Solid-Dispersible Self-Emulsifying Drug Delivery Systems for Dual Drug Delivery. Pharmaceutics. 2026;18(6):637.","journal-title":"Pharmaceutics"},{"issue":"3","key":"671_CR71","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/pharmaceutics18030305","volume":"18","author":"ML Gonz\u00e1lez-Rodr\u00edguez","year":"2026","unstructured":"Gonz\u00e1lez-Rodr\u00edguez ML, Valverde-Cabeza S, P\u00e9rez-Terr\u00f3n E, Rabasco AM, Gonz\u00e1lez-Rodriguez PL. Advanced Optimization of Clonazepam-Loaded Solid Self-Emulsifying Drug Delivery Systems: Comparison of Weighted Goal Programming and Desirability Function in a Quality by Design Framework. Pharmaceutics. 2026;18(3):305.","journal-title":"Pharmaceutics"},{"key":"671_CR72","doi-asserted-by":"crossref","unstructured":"Lonlab K, Nitjapol A, Thummayot S, Tiyaboonchai W, Jumnongprakhon P. Targeting A\u03b225-35-Induced Neuronal Senescence-Like Features Using Curcumin-Loaded Solid Self-Emulsifying Drug Delivery Systems. Current Aging Science; 2026.","DOI":"10.2174\/0118746098440081260430205824"},{"key":"671_CR73","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2026.2675542","author":"P Pan","year":"2026","unstructured":"Pan P, Ma Y, Kong S, Ahmed K, Wu Z. Liposomes in oral delivery: Mechanisms, advances, challenges, and future perspectives. J Liposome Res. 2026. https:\/\/doi.org\/10.1080\/08982104.2026.2675542. Advance online publication.","journal-title":"J Liposome Res"},{"key":"671_CR74","doi-asserted-by":"crossref","unstructured":"Jin, P., Wu, S., Wang, Y., Ni, Y., Ruan, Q., Yuan, Z., \u2026 Li, J. (2026). Surface modification strategies of oral liposomes: functional design and barrier enhancement. Frontiers in Pharmacology, 17, 1801527.","DOI":"10.3389\/fphar.2026.1801527"},{"key":"671_CR75","doi-asserted-by":"crossref","unstructured":"Jin, P., Wu, S., Wang, Y., Ni, Y., Ruan, Q., Yuan, Z., \u2026 Li, J. (2026). Surface modification strategies of oral liposomes: functional design and barrier enhancement. Frontiers in Pharmacology, 17, 1801527.","DOI":"10.3389\/fphar.2026.1801527"},{"key":"671_CR76","doi-asserted-by":"publisher","first-page":"103887","DOI":"10.1016\/j.cis.2026.103887","volume":"353","author":"X Zhang","year":"2026","unstructured":"Zhang X, Liu W, Chu H, Zong W. Liposomes: a breakthrough in advanced drug delivery systems. Adv Colloid Interface Sci. 2026;353:103887. https:\/\/doi.org\/10.1016\/j.cis.2026.103887.","journal-title":"Adv Colloid Interface Sci"},{"key":"671_CR77","unstructured":"Altaee MAT. (2026). Formulation, Optimisation and Characterisation of pH Gradient Niosomes: Active Loading of Bromocresol Green and Doxorubicin (Doctoral dissertation, The University of Sunderland)."},{"key":"671_CR78","unstructured":"Amer A. (2026). Formulation, characterisation and evaluation of peptide-loaded nanoniosomal delivery systems prepared by microfluidic technique and incorporated into oral dispersible films (Doctoral dissertation, The University of Sunderland)."},{"issue":"1","key":"671_CR79","first-page":"112","volume":"4","author":"MJ Altube","year":"2026","unstructured":"Altube MJ, Morilla MJ, Perez AP. Optimizing Niosomes as Nanocarriers for Topical Antipsoriatic Therapy: A Mini-Review. J Basic Appl Pharm Sci. 2026;4(1):112.","journal-title":"J Basic Appl Pharm Sci"},{"issue":"1","key":"671_CR80","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s11671-026-04676-6","volume":"21","author":"A Staniszewska","year":"2026","unstructured":"Staniszewska A, Kala D, Kuryk \u0141, Borkowska A, Kuma S, Staniszewska M. Lipid-based nanocarriers for antifungal drug delivery. Discover Nano. 2026;21(1):298.","journal-title":"Discover Nano"},{"key":"671_CR81","unstructured":"Maity B. (2026). Novel Herbal Drug Delivery Systems and Nanophytomedicines. A Textbook of Pharmaceutical Biotechnology, 167."},{"key":"671_CR82","doi-asserted-by":"publisher","unstructured":"Pereira AR, Mateus N, de Freitas V, Fernandes A. Encapsulation strategies for enhancing stability, bioavailability, and functionality of acylated anthocyanins. Acylated Anthocyanins. CRC; 2026. pp. 232\u201353. https:\/\/doi.org\/10.1201\/9781003519591-18.","DOI":"10.1201\/9781003519591-18"},{"issue":"6","key":"671_CR83","doi-asserted-by":"publisher","first-page":"e70635","DOI":"10.1111\/jfpe.70635","volume":"49","author":"SI Abduljabbar","year":"2026","unstructured":"Abduljabbar SI, Khan J, Azad F, Ahmed FJ, Panda BP. Optimized low-temperature ultrasonicated mk-7 nanoemulsion: characterization, stability, and bioavailability potential. J Food Process Eng. 2026;49(6):e70635. https:\/\/doi.org\/10.1111\/jfpe.70635.","journal-title":"J Food Process Eng"},{"key":"671_CR84","doi-asserted-by":"crossref","unstructured":"Melk, M. M., Abdallah, A. K., Abdelkader, F. A., Hassan, A. A., Youssef, A. S., Gomaa,E., \u2026 El-Sayyad, G. S. (2026). Current Developments in Green Nanoemulsion Technology:Biomass-Assisted Synthesis, Characterization, and Implications for the Environment and Biomedicine. BioNanoScience, 16(5), 344.","DOI":"10.1007\/s12668-026-02505-9"},{"issue":"6","key":"671_CR85","doi-asserted-by":"publisher","first-page":"11842","DOI":"10.1007\/s11694-026-04446-z","volume":"20","author":"LA Lew","year":"2026","unstructured":"Lew LA, Okechukwu NP, Tan TB, Tan CP, Tan CH. Impacts of high-pressure homogenization and spontaneous emulsification on the physicochemical properties and stability of red palm olein-based beta-carotene nanoemulsion. J Food Meas Charact. 2026;20(6):11842\u201356. https:\/\/doi.org\/10.1007\/s11694-026-04446-z.","journal-title":"J Food Meas Charact"},{"key":"671_CR86","doi-asserted-by":"publisher","unstructured":"Jabbari H. (2026). Dendrimers and their Application in Drug Delivery: A Review. Current drug research reviews, 10.2174\/0125899775405321260127055256. Advance online publication. https:\/\/doi.org\/10.2174\/0125899775405321260127055256","DOI":"10.2174\/0125899775405321260127055256"},{"issue":"1","key":"671_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14715\/cmb\/2025.70.1.1","volume":"71","author":"MM Zorab","year":"2025","unstructured":"Zorab MM, Qadir AM, Ahmed AMA. Dendrimers as drug delivery vehicles: A comprehensive review. Cell Mol Biol. 2025;71(1):1\u201312. https:\/\/doi.org\/10.14715\/cmb\/2025.70.1.1.","journal-title":"Cell Mol Biol"},{"issue":"2","key":"671_CR88","doi-asserted-by":"publisher","first-page":"e1173773","DOI":"10.1080\/21688370.2016.1173773","volume":"4","author":"VK Yellepeddi","year":"2016","unstructured":"Yellepeddi VK, Ghandehari H. Poly(amido amine) dendrimers in oral delivery. Tissue barriers. 2016;4(2):e1173773. https:\/\/doi.org\/10.1080\/21688370.2016.1173773.","journal-title":"Tissue barriers"},{"issue":"7","key":"671_CR89","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1021\/acsabm.5c00498","volume":"8","author":"MA Raza","year":"2025","unstructured":"Raza MA, Firdous A, Gupta U, Patil U, Singh A, Ajazuddin. Emerging trends in designing dendrimer-based drug delivery for antineoplastic therapies. ACS Appl Bio Mater. 2025;8(7):5462\u201395. https:\/\/doi.org\/10.1021\/acsabm.5c00498.","journal-title":"ACS Appl Bio Mater"},{"key":"671_CR90","doi-asserted-by":"publisher","unstructured":"Jabbari H. (2026). Dendrimers and their Application in Drug Delivery: A Review. Current drug research reviews, 10.2174\/0125899775405321260127055256. Advance online publication. https:\/\/doi.org\/10.2174\/0125899775405321260127055256","DOI":"10.2174\/0125899775405321260127055256"},{"issue":"11","key":"671_CR91","doi-asserted-by":"publisher","first-page":"e202500359","DOI":"10.1002\/cbdv.202500359","volume":"22","author":"H Khatoon","year":"2025","unstructured":"Khatoon H, Faudzi SMM, Sohajda T. Mechanisms and therapeutic applications of \u03b2-cyclodextrin in drug solubilisation and delivery systems. Chem Biodivers. 2025;22(11):e202500359. https:\/\/doi.org\/10.1002\/cbdv.202500359.","journal-title":"Chem Biodivers"},{"issue":"14","key":"671_CR92","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/molecules30143044","volume":"30","author":"I Spiridon","year":"2025","unstructured":"Spiridon I, Anghel N. Cyclodextrins as multifunctional platforms in drug delivery and beyond: Structural features, functional applications, and future trends. Molecules. 2025;30(14):3044. https:\/\/doi.org\/10.3390\/molecules30143044.","journal-title":"Molecules"},{"issue":"14","key":"671_CR93","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/molecules30143044","volume":"30","author":"I Spiridon","year":"2025","unstructured":"Spiridon I, Anghel N. Cyclodextrins as multifunctional platforms in drug delivery and beyond: Structural features, functional applications, and future trends. Molecules. 2025;30(14):3044. https:\/\/doi.org\/10.3390\/molecules30143044.","journal-title":"Molecules"},{"key":"671_CR94","doi-asserted-by":"crossref","unstructured":"Bhardwaj, S., Gauniya, P., Chitra, Radheshyam, Semalty, A., Gupta, M., \u2026 Semalty,M. (2026). \u03b2-Cyclodextrin\/Chitosan Microparticles for Sustained Release of Dapagliflozin. Micro and Nanosystems.","DOI":"10.2174\/0118764029410663251128190121"},{"issue":"2","key":"671_CR95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00289-025-06071-0","volume":"83","author":"SS Panditkar","year":"2026","unstructured":"Panditkar SS, Gurnule WB, Waghe PU, Gurnule PW, Kumar P. The art and science of electrospinning: A detailed review of process and potential applications. Polym Bull. 2026;83(2):53.","journal-title":"Polym Bull"},{"issue":"9","key":"671_CR96","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/ph18091392","volume":"18","author":"F Benk\u0151","year":"2025","unstructured":"Benk\u0151 F, Krist\u00f3 K, Sov\u00e1ny T. Mesoporous Silica Nanoparticles as Drug Delivery Systems. Pharmaceuticals (Basel Switzerland). 2025;18(9):1392. https:\/\/doi.org\/10.3390\/ph18091392.","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"key":"671_CR97","doi-asserted-by":"publisher","first-page":"113603","DOI":"10.1016\/j.micromeso.2025.113603","volume":"391","author":"MI Grini","year":"2025","unstructured":"Grini MI, Benbayer C, Saidi-Besbes S, Elaissari A. Advances in mesoporous silica nanoparticles as carriers for drug delivery and other biomedical applications. Microporous Mesoporous Mater. 2025;391:113603. https:\/\/doi.org\/10.1016\/j.micromeso.2025.113603.","journal-title":"Microporous Mesoporous Mater"},{"issue":"9","key":"671_CR98","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/ph18091392","volume":"18","author":"F Benk\u0151","year":"2025","unstructured":"Benk\u0151 F, Krist\u00f3 K, Sov\u00e1ny T. Mesoporous silica nanoparticles as drug delivery systems. Pharmaceuticals. 2025;18(9):1392. https:\/\/doi.org\/10.3390\/ph18091392.","journal-title":"Pharmaceuticals"},{"key":"671_CR99","doi-asserted-by":"publisher","first-page":"1564188","DOI":"10.3389\/fnano.2025.1564188","volume":"7","author":"R Fatima","year":"2025","unstructured":"Fatima R, Katiyar P, Kushwaha K. Recent advances in mesoporous silica nanoparticles: Synthesis, drug loading, release mechanisms, and diverse applications. Front Nanatechnol. 2025;7:1564188. https:\/\/doi.org\/10.3389\/fnano.2025.1564188.","journal-title":"Front Nanatechnol"},{"issue":"1","key":"671_CR100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11101-025-10118-5","volume":"25","author":"S Chaubey","year":"2026","unstructured":"Chaubey S, Rastogi N, Srivastava M. Exploring the medicinal potential of Lantana camara: a comprehensive review of phytochemicals and therapeutic application. Phytochem Rev. 2026;25(1):23\u201353.","journal-title":"Phytochem Rev"},{"issue":"6","key":"671_CR101","doi-asserted-by":"publisher","first-page":"e03151","DOI":"10.1002\/cbdv.202503151","volume":"23","author":"S Chaubey","year":"2026","unstructured":"Chaubey S, Singh KJ, Srivastava M. Integrated in vitro and in silico evaluation of lotus (Nelumbo nucifera) seed extracts for antioxidant, antimicrobial, and antidiabetic potentials. Chem Biodivers. 2026;23(6):e03151. https:\/\/doi.org\/10.1002\/cbdv.202503151.","journal-title":"Chem Biodivers"},{"issue":"1","key":"671_CR102","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s44371-026-00570-3","volume":"3","author":"S Maurya","year":"2026","unstructured":"Maurya S, Anupam, Tripathi S, Chaubey S, Soni A. Recent advances in the synthesis and applications of zinc oxide nanomaterials for healthcare energy and environmental systems. Discover Chem. 2026;3(1):98.","journal-title":"Discover Chem"},{"key":"671_CR103","doi-asserted-by":"crossref","unstructured":"Arya, M., Jaiswal, M., Ram, A., Chaubey, S., Gautam, S. K., Singh, K., \u2026 Singh, S.K. (2026). Synthesis, computational profiling, and anti-inflammatory potential of a thymol-mefenamic acid hybrid derivative. Spectroscopy Letters, 59(3), 200\u2013219.","DOI":"10.1080\/00387010.2025.2505185"},{"key":"671_CR104","doi-asserted-by":"publisher","first-page":"125380","DOI":"10.1016\/j.ijpharm.2025.125380","volume":"673","author":"MT Khulood","year":"2025","unstructured":"Khulood MT, Jijith US, Naseef PP, Kallungal SM, Geetha VS, Pramod K. Advances in metal-organic framework-based drug delivery systems. Int J Pharm. 2025;673:125380. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125380.","journal-title":"Int J Pharm"},{"issue":"5","key":"671_CR105","doi-asserted-by":"publisher","first-page":"e70272","DOI":"10.1111\/1541-4337.70272","volume":"24","author":"H Yang","year":"2025","unstructured":"Yang H, Luan Q, Guan W, Nong W. Oral delivery systems of dietary bioactive compounds based on metal-organic frameworks: A review. Compr Rev Food Sci Food Saf. 2025;24(5):e70272. https:\/\/doi.org\/10.1111\/1541-4337.70272.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"671_CR106","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1016\/j.apsb.2024.06.011","volume":"14","author":"W Wu","year":"2024","unstructured":"Wu W, et al. Metal-organic frameworks in oral drug delivery. Acta Pharm Sinica B. 2024;14:4518\u201352. https:\/\/doi.org\/10.1016\/j.apsb.2024.06.011.","journal-title":"Acta Pharm Sinica B"},{"issue":"5","key":"671_CR107","doi-asserted-by":"publisher","first-page":"100951","DOI":"10.1016\/j.ajps.2024.100951","volume":"19","author":"A Raza","year":"2024","unstructured":"Raza A, Wu W. Metal-organic frameworks in oral drug delivery. Asian J Pharm Sci. 2024;19(5):100951. https:\/\/doi.org\/10.1016\/j.ajps.2024.100951.","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"671_CR108","doi-asserted-by":"publisher","first-page":"2624192","DOI":"10.1080\/10717544.2026.2624192","volume":"33","author":"Y Zheng","year":"2026","unstructured":"Zheng Y, Fang X, Gao J. Re-engineering insulin for oral delivery: structural modifications, advanced formulation strategies, and future directions. Drug Delivery. 2026;33(1):2624192. https:\/\/doi.org\/10.1080\/10717544.2026.2624192.","journal-title":"Drug Delivery"},{"issue":"2","key":"671_CR109","doi-asserted-by":"publisher","first-page":"e00661","DOI":"10.1002\/mabi.202500661","volume":"26","author":"K Gopal","year":"2026","unstructured":"Gopal K, Chellathurai MS, Sofian ZM, Aramwit P, Mahmood S. Design and evaluation of chitosan-coated liposomal microneedle capsules for oral insulin delivery: a proof of concept. Macromol Biosci. 2026;26(2):e00661. https:\/\/doi.org\/10.1002\/mabi.202500661.","journal-title":"Macromol Biosci"},{"key":"671_CR110","doi-asserted-by":"crossref","unstructured":"Thamizhchelvan, A. M., Li, Y., Padelford, J., Yang, C., Yang, C., He, P., \u2026 Mao, H.(2026). Small Intestine-Targeted Long-Acting Oral Insulin Formulation Based on Engineered Milk Protein Nanoparticles. ACS Applied Bio Materials, 9(2), 1083\u20131097.","DOI":"10.1021\/acsabm.5c02114"},{"issue":"7","key":"671_CR111","doi-asserted-by":"publisher","first-page":"rgag078","DOI":"10.1093\/jpp\/rgag078","volume":"78","author":"HF Chang","year":"2026","unstructured":"Chang HF, Lin TM, Sun YL, Lin TC, Lin CS. The latest developments in oral insulin: scientific advances and clinical progress. J Pharm Pharmacol. 2026;78(7):rgag078.","journal-title":"J Pharm Pharmacol"},{"key":"671_CR112","doi-asserted-by":"crossref","unstructured":"Kassab MMS. (2026). Mechanism-Guided Engineering of a Protease-Resistant, Acid-Stable Insulin Analog (InsuRFPK) Enabling Oral and Sublingual Delivery with Enhanced Bioavailability. Acid-Stable Insulin Analog (InsuRFPK) Enabling Oral and Sublingual Delivery with Enhanced Bioavailability (May 16, 2026).","DOI":"10.2139\/ssrn.6777865"},{"issue":"20","key":"671_CR113","doi-asserted-by":"publisher","first-page":"28368","DOI":"10.1021\/acsami.5c24385","volume":"18","author":"J Tao","year":"2026","unstructured":"Tao J, Lu X, Wei Y, Feng J, Yang J, Qi J. An Ionic Liquid-Based Enteric Formulation for Enhanced Oral Delivery of Semaglutide in Type 2 Diabetes Mellitus. ACS Appl Mater Interfaces. 2026;18(20):28368\u201380.","journal-title":"ACS Appl Mater Interfaces"},{"key":"671_CR114","doi-asserted-by":"publisher","first-page":"1833440","DOI":"10.3389\/fnut.2026.1833440","volume":"13","author":"YM Yal\u00e7\u0131nta\u015f","year":"2026","unstructured":"Yal\u00e7\u0131nta\u015f YM, Karav S, A\u01e7ag\u00fcnd\u00fcz D. Lactoferrin as a multi-target nutritional modulator in type-2 diabetes. Front Nutr. 2026;13:1833440.","journal-title":"Front Nutr"},{"key":"671_CR115","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/IJN.S505427","volume":"20","author":"B Zheng","year":"2025","unstructured":"Zheng B, Liu D, Qin X, Zhang D, Zhang P. Mucoadhesive-to-mucopenetrating nanoparticles for mucosal drug delivery: A mini review. Int J Nanomed. 2025;20:2241\u201352. https:\/\/doi.org\/10.2147\/IJN.S505427.","journal-title":"Int J Nanomed"},{"issue":"5","key":"671_CR116","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.5281\/zenodo.15535003","volume":"3","author":"A Bhoyar","year":"2025","unstructured":"Bhoyar A, Harsulkar A, Jadhav A, Kadam A. Advances in mucoadhesive oral drug delivery: Mechanisms, polymers, and therapeutic applications. Int J Pharm Sci. 2025;3(5):4510\u201326. https:\/\/doi.org\/10.5281\/zenodo.15535003.","journal-title":"Int J Pharm Sci"},{"issue":"7","key":"671_CR117","doi-asserted-by":"publisher","first-page":"e202600022","DOI":"10.1002\/cnma.202600022","volume":"12","author":"N Paul","year":"2026","unstructured":"Paul N, Modak SS, Bej R. Engineered mucoadhesive and mucopenetrating biomaterials for ocular drug delivery. ChemNanoMat. 2026;12(7):e202600022. https:\/\/doi.org\/10.1002\/cnma.202600022.","journal-title":"ChemNanoMat"},{"key":"671_CR118","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12951-025-03479-8","volume":"23","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li X, Wang H, et al. Advanced oral drug delivery systems for gastrointestinal targeted delivery: The design principles and foundations. J Nanobiotechnol. 2025;23:421. https:\/\/doi.org\/10.1186\/s12951-025-03479-8.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"671_CR119","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.mucimm.2025.01.009","volume":"18","author":"Y Oya","year":"2025","unstructured":"Oya Y, Kimura S, Uemura M, Fujimura Y, Hase K. Tear duct M cells exacerbate allergic conjunctivitis by facilitating germinal-center reactions. Mucosal Immunol. 2025;18(3):549\u201361.","journal-title":"Mucosal Immunol"},{"key":"671_CR120","doi-asserted-by":"crossref","unstructured":"Wang, D., Lim, S., Van De Wetering, W. J., Lopez-Iglesias, C., Okura, Y., Teranishi-Ikawa,Y., \u2026 Clevers, H. (2026). Human gut M cells resemble dendritic cells and present gluten antigen. Nature, 650(8100), 251\u2013260.","DOI":"10.1038\/s41586-025-09829-8"},{"issue":"11","key":"671_CR121","doi-asserted-by":"publisher","first-page":"105846","DOI":"10.1016\/j.psj.2025.105846","volume":"104","author":"MZU Rubel","year":"2025","unstructured":"Rubel MZU, Namba T, Hiraishi M, Oe S, Ichii O. Age- and sex-dependent morphological alterations of rectal mucosa-associated lymphoid tissue in chickens (Gallus gallus domesticus). Poult Sci. 2025;104(11):105846.","journal-title":"Poult Sci"},{"key":"671_CR122","doi-asserted-by":"publisher","first-page":"1778142","DOI":"10.3389\/fphar.2026.1778142","volume":"17","author":"S Zuo","year":"2026","unstructured":"Zuo S, Kurumi H, Ogihara R, Kanda T, Isomoto H. Gut microbiota\u2013M cell co-culture in inflammatory bowel disease and its therapeutic potential in organoid platforms. Front Pharmacol. 2026;17:1778142.","journal-title":"Front Pharmacol"},{"key":"671_CR123","doi-asserted-by":"crossref","unstructured":"Zhang, W., Xi, G., Zhang, H., Bi, J., Zhou, T., Zhu, J., \u2026 Wang, J. (2025). Pasteurized Akkermansia muciniphila promotes GP2 expression in microfold cells and facilitates Salmonella infection. Protein & Cell, 16(9), 829\u2013834.","DOI":"10.1093\/procel\/pwaf017"},{"key":"671_CR124","doi-asserted-by":"crossref","unstructured":"Zhang, W., Xi, G., Zhang, H., Bi, J., Zhou, T., Zhu, J., \u2026 Wang, J. (2025). Pasteurized Akkermansia muciniphila promotes GP2 expression in microfold cells and facilitates Salmonella infection. Protein & Cell, 16(9), 829\u2013834.","DOI":"10.1093\/procel\/pwaf017"},{"issue":"36","key":"671_CR125","doi-asserted-by":"publisher","first-page":"40901","DOI":"10.1021\/acsomega.5c01703","volume":"10","author":"S Rejinold","year":"2025","unstructured":"Rejinold S, Kim JY, Jin GW, Choi G, Choy JH. Transport Mechanisms of 2D Nanoparticles across a Human Follicle-Associated Epithelium Model. ACS omega. 2025;10(36):40901.","journal-title":"ACS omega"},{"key":"671_CR126","doi-asserted-by":"crossref","unstructured":"Tan H, Tang M, Che Y, Li X, Tu Z, Zhao X, Wan H. (2025). Virus like nanoparticles of VLP-BSA-iRGD enhanced mucosal immune response by targeting M cells. Colloids Surf B, 115296.","DOI":"10.1016\/j.colsurfb.2025.115296"},{"key":"671_CR127","doi-asserted-by":"crossref","unstructured":"Li, J., Feng, M., Chen, N., Shan, P., Fung, H., Zhang, X., \u2026 Han, Q. (2026). Identification of a commercial Xylan as a microfold cell-targeting polysaccharide in vivo and in vitro. International Journal of Biological Macromolecules, 153501.","DOI":"10.1016\/j.ijbiomac.2026.153501"},{"issue":"3","key":"671_CR128","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/21645515.2015.1102804","volume":"12","author":"M Allahyari","year":"2016","unstructured":"Allahyari M, Mohit E. Peptide\/protein vaccine delivery system based on PLGA particles. Hum vaccines immunotherapeutics. 2016;12(3):806\u201328. https:\/\/doi.org\/10.1080\/21645515.2015.1102804.","journal-title":"Hum vaccines immunotherapeutics"},{"key":"671_CR129","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12951-020-00750-y","volume":"19","author":"MS Kim","year":"2021","unstructured":"Kim MS, Han HY, Kwon IC, Kim IS. Development of an M cell targeted nanocomposite system for effective oral protein delivery: Preparation, in vitro and in vivo characterization. J Nanobiotechnol. 2021;19:2. https:\/\/doi.org\/10.1186\/s12951-020-00750-y.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"671_CR130","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","volume":"64","author":"LM Ensign","year":"2012","unstructured":"Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64(6):557\u201370.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"671_CR131","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0264-410X(01)00258-4","volume":"20","author":"MA Clark","year":"2001","unstructured":"Clark MA, Jepson MA, Hirst BH. Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine. 2001;20(1\u20132):208\u201317. https:\/\/doi.org\/10.1016\/S0264-410X(01)00258-4.","journal-title":"Vaccine"},{"issue":"1\u20132","key":"671_CR132","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijpharm.2005.01.018","volume":"294","author":"N Zhang","year":"2005","unstructured":"Zhang N, Ping Q, Huang G, Xu W. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm. 2005;294(1\u20132):247\u201359. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.01.018.","journal-title":"Int J Pharm"},{"key":"671_CR133","doi-asserted-by":"publisher","unstructured":"Zheng Y et al. (2026). Re-engineering insulin for oral delivery: Structural optimization and nanotechnology-based delivery strategies. Drug Delivery. Advance online publication. https:\/\/doi.org\/10.1080\/10717544.2026.2624192","DOI":"10.1080\/10717544.2026.2624192"},{"key":"671_CR134","doi-asserted-by":"publisher","first-page":"107844","DOI":"10.1016\/j.phrs.2025.107844","volume":"218","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu C, An D, Deng S, Liu G. Engineered nanomaterials for overcoming multifaceted gastrointestinal barriers: Toward precision oral delivery of therapeutics. Pharmacol Res. 2025;218:107844.","journal-title":"Pharmacol Res"},{"issue":"1","key":"671_CR135","doi-asserted-by":"publisher","first-page":"2624192","DOI":"10.1080\/10717544.2026.2624192","volume":"33","author":"Y Zheng","year":"2026","unstructured":"Zheng Y, Fang X, Gao J. Re-engineering insulin for oral delivery: structural modifications, advanced formulation strategies, and future directions. Drug Delivery. 2026;33(1):2624192.","journal-title":"Drug Delivery"},{"issue":"Supplement2","key":"671_CR136","first-page":"zwag249","volume":"33","author":"BS Chan","year":"2026","unstructured":"Chan BS, Li PWC, Yu DSF. Digital lifestyle re-engineering with maintenance phase design: The TOP-S randomised clinical trial in metabolic syndrome management. Eur J Prev Cardiol. 2026;33(Supplement2):zwag249\u2013282.","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"671_CR137","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3390\/pharmaceutics17121563","volume":"17","author":"G Fontana","year":"2025","unstructured":"Fontana G, Innamorati G, Giacomello L. Nanoparticle-Based Oral Insulin Delivery: Challenges, Advances, and Future Directions. Pharmaceutics. 2025;17(12):1563. https:\/\/doi.org\/10.3390\/pharmaceutics17121563.","journal-title":"Pharmaceutics"},{"issue":"1","key":"671_CR138","doi-asserted-by":"publisher","first-page":"2624192","DOI":"10.1080\/10717544.2026.2624192","volume":"33","author":"Y Zheng","year":"2026","unstructured":"Zheng Y, Fang X, Gao J. Re-engineering insulin for oral delivery: structural modifications, advanced formulation strategies, and future directions. Drug Delivery. 2026;33(1):2624192.","journal-title":"Drug Delivery"},{"key":"671_CR139","unstructured":"Puthukudi AK, Kamalasanan K, Ganga PP et al. (2026). Towards oral insulin-controlled release nanomedicine: A review. Artificial Cells, Nanomedicine, and Biotechnology."},{"issue":"12","key":"671_CR140","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3390\/pharmaceutics17121563","volume":"17","author":"G Fontana","year":"2025","unstructured":"Fontana G, Innamorati G, Giacomello L. Nanoparticle-based oral insulin delivery: challenges, advances, and future directions. Pharmaceutics. 2025;17(12):1563.","journal-title":"Pharmaceutics"},{"issue":"4","key":"671_CR141","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1208\/s12249-015-0350-9","volume":"16","author":"S Amidon","year":"2015","unstructured":"Amidon S, Brown JE, Dave VS. Colon-targeted drug delivery systems: An overview of various approaches and recent advances. AAPS PharmSciTech. 2015;16(4):731\u201341. https:\/\/doi.org\/10.1208\/s12249-015-0350-9.","journal-title":"AAPS PharmSciTech"},{"key":"671_CR142","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jconrel.2020.09.022","volume":"328","author":"SH Lee","year":"2020","unstructured":"Lee SH, Zhang Z, McClements DJ. Azoreductase-responsive azo-crosslinked polymeric nanoparticles for site-specific colonic delivery of peptide therapeutics. J Controlled Release. 2020;328:420\u201331. https:\/\/doi.org\/10.1016\/j.jconrel.2020.09.022.","journal-title":"J Controlled Release"},{"issue":"1\u20132","key":"671_CR143","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0378-5173(01)00720-7","volume":"224","author":"VR Sinha","year":"2001","unstructured":"Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm. 2001;224(1\u20132):19\u201338. https:\/\/doi.org\/10.1016\/s0378-5173(01)00720-7.","journal-title":"Int J Pharm"},{"issue":"5","key":"671_CR144","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1021\/nn400630x","volume":"7","author":"Z Gu","year":"2013","unstructured":"Gu Z, Aimetti AA, Wang Q, Dang TT, Zhang Y, Veiseh O, Cheng H, Langer RS, Anderson DG. Injectable nano-network for glucose-mediated insulin delivery. ACS Nano. 2013;7(5):4194\u2013201. https:\/\/doi.org\/10.1021\/nn400630x.","journal-title":"ACS Nano"},{"key":"671_CR145","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/IJN.S284357","volume":"16","author":"Q Ma","year":"2021","unstructured":"Ma Q, Zhao X, Shi A, Wu J. Bioresponsive functional phenylboronic acid-based delivery system as an emerging platform for diabetic therapy. Int J Nanomed. 2021;16:297\u2013314. https:\/\/doi.org\/10.2147\/IJN.S284357.","journal-title":"Int J Nanomed"},{"key":"671_CR146","doi-asserted-by":"publisher","first-page":"118932","DOI":"10.1016\/j.carbpol.2021.118932","volume":"278","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao Y, Wang K. Phenylboronic acid-functionalized chitosan nanoparticles for glucose-responsive oral insulin delivery. Carbohydr Polym. 2022;278:118932. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118932.","journal-title":"Carbohydr Polym"},{"issue":"9","key":"671_CR147","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circul Res. 2010;107(9):1058\u201370. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223545.","journal-title":"Circul Res"},{"issue":"7","key":"671_CR148","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1021\/acs.biomac.9b00628","volume":"20","author":"H Ye","year":"2019","unstructured":"Ye H, Zhou Y, Liu X, Chen Y, Duan S, Zhu R, Liu Y, Yin L. Recent advances on reactive oxygen species-responsive delivery and diagnosis system. Biomacromolecules. 2019;20(7):2441\u201363. https:\/\/doi.org\/10.1021\/acs.biomac.9b00628.","journal-title":"Biomacromolecules"},{"issue":"11","key":"671_CR149","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nmat2859","volume":"9","author":"DS Wilson","year":"2010","unstructured":"Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N. Orally delivered thioketal nanoparticles loaded with TNF-\u03b1-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater. 2010;9(11):923\u20138. https:\/\/doi.org\/10.1038\/nmat2859.","journal-title":"Nat Mater"},{"key":"671_CR150","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.biomaterials.2018.06.033","volume":"178","author":"Q Xu","year":"2018","unstructured":"Xu Q, He C, Xiao C, Chen X. Reactive oxygen species (ROS)-responsive diselenide-containing amphiphilic copolymers for targeted anti-diabetic therapy. Biomaterials. 2018;178:332\u201342. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.06.033.","journal-title":"Biomaterials"},{"issue":"8","key":"671_CR151","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","volume":"59","author":"LM Bareford","year":"2007","unstructured":"Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev. 2007;59(8):748\u201358. https:\/\/doi.org\/10.1016\/j.addr.2007.06.008.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"671_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2013.07.001","volume":"8","author":"L Kou","year":"2013","unstructured":"Kou L, Sun J, Zhai Y, He Z. The endocytosis and intracellular fate of nanomedicines: Implication for rational design. Asian J Pharm Sci. 2013;8(1):1\u201310. https:\/\/doi.org\/10.1016\/j.ajps.2013.07.001.","journal-title":"Asian J Pharm Sci"},{"issue":"1\u20132","key":"671_CR153","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2533\/chimia.1997.34","volume":"51","author":"JP Behr","year":"1997","unstructured":"Behr JP. The proton sponge: A means to enter cells virus-free. Chimia. 1997;51(1\u20132):34\u20136.","journal-title":"Chimia"},{"issue":"3","key":"671_CR154","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrm2122","volume":"8","author":"RG Parton","year":"2007","unstructured":"Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007;8(3):185\u201394. https:\/\/doi.org\/10.1038\/nrm2122.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"671_CR155","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1021\/bm050265y","volume":"6","author":"MF Francis","year":"2005","unstructured":"Francis MF, Cristea M, Winnik FM. Polymeric micelles for oral drug delivery: Endocytosis and transcytosis across Caco-2 monolayers. Biomacromolecules. 2005;6(5):2462\u20137. https:\/\/doi.org\/10.1021\/bm050265y.","journal-title":"Biomacromolecules"},{"issue":"4","key":"671_CR156","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1600-0854.2009.00878.x","volume":"10","author":"MC Kerr","year":"2009","unstructured":"Kerr MC, Teasdale RD. Defining macropinocytosis. Traffic. 2009;10(4):364\u201371. https:\/\/doi.org\/10.1111\/j.1600-0854.2009.00878.x.","journal-title":"Traffic"},{"issue":"13","key":"671_CR157","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.062","volume":"31","author":"C He","year":"2010","unstructured":"He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and transcytosis of polymeric nanoparticles across intestinal mucosa. Biomaterials. 2010;31(13):3657\u201366. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.01.062.","journal-title":"Biomaterials"},{"issue":"2","key":"671_CR158","doi-asserted-by":"publisher","first-page":"a002584","DOI":"10.1101\/cshperspect.a002584","volume":"1","author":"JM Anderson","year":"2009","unstructured":"Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 2009;1(2):a002584. https:\/\/doi.org\/10.1101\/cshperspect.a002584.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"671_CR159","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.addr.2016.04.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277\u2013319. https:\/\/doi.org\/10.1016\/j.addr.2016.04.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"671_CR160","doi-asserted-by":"publisher","first-page":"195","DOI":"10.15171\/apb.2019.023","volume":"9","author":"U Garg","year":"2019","unstructured":"Garg U, Chauhan S, Nagaich U, Jain N. Current advances in chitosan nanoparticles based drug delivery and targeting. Adv Pharm Bull. 2019;9(2):195\u2013204. https:\/\/doi.org\/10.15171\/apb.2019.023.","journal-title":"Adv Pharm Bull"},{"issue":"9","key":"671_CR161","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3390\/pharmaceutics15092361","volume":"15","author":"T Sangnim","year":"2023","unstructured":"Sangnim T, Dheer D, Jangra N, Huanbutta K, Puri V, Sharma A. Chitosan in oral drug delivery formulations: A review. Pharmaceutics. 2023;15(9):2361. https:\/\/doi.org\/10.3390\/pharmaceutics15092361.","journal-title":"Pharmaceutics"},{"issue":"4","key":"671_CR162","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/10611869608995624","volume":"4","author":"M Tomita","year":"1996","unstructured":"Tomita M, Shiga M, Hayashi M, Awazu S. Enhancing effect of EDTA on the paracellular permeability of water-soluble compounds in Caco-2 cell monolayers. J Drug Target. 1996;4(4):225\u201332. https:\/\/doi.org\/10.3109\/10611869608995624.","journal-title":"J Drug Target"},{"issue":"3","key":"671_CR163","first-page":"1358","volume":"275","author":"T Lindmark","year":"1995","unstructured":"Lindmark T, Nikkil\u00e4 T, Artursson P. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther. 1995;275(3):1358\u201364.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"671_CR164","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/s0168-3659(01)00343-4","volume":"74","author":"M Thanou","year":"2001","unstructured":"Thanou M, Nihot MT, Jansen M, Verhoef JC, Junginger HE. Mono-N-carboxymethyl chitosan (MCC) as a potential absorption enhancer for oral peptide delivery in vivo and in vitro. J Controlled Release. 2001;74(1\u20133):289\u201394. https:\/\/doi.org\/10.1016\/s0168-3659(01)00343-4.","journal-title":"J Controlled Release"},{"key":"671_CR165","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.addr.2015.03.006","volume":"90","author":"NL Trevaskis","year":"2015","unstructured":"Trevaskis NL, Kaminskas LM, Porter CJH. From sewer to highway: Regulation of intestinal lymphatic transport. Adv Drug Deliv Rev. 2015;90:98\u2013111. https:\/\/doi.org\/10.1016\/j.addr.2015.03.006.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"671_CR166","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/s0928-0987(02)00051-9","volume":"15","author":"CM O\u2019Driscoll","year":"2002","unstructured":"O\u2019Driscoll CM. Lipid-based formulations for intestinal lymphatic transport. Eur J Pharm Sci. 2002;15(5):405\u201315. https:\/\/doi.org\/10.1016\/s0928-0987(02)00051-9.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"671_CR167","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrd2197","volume":"6","author":"CJH Porter","year":"2007","unstructured":"Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discovery. 2007;6(3):231\u201348. https:\/\/doi.org\/10.1038\/nrd2197.","journal-title":"Nat Rev Drug Discovery"},{"issue":"8","key":"671_CR168","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/1520-6017(200008)89:8<1073::AID-JPS11>3.0.CO;2-C","volume":"89","author":"SM Caliph","year":"2000","unstructured":"Caliph SM, Charman WN, Porter CJH. Effect of lipid volume on intestinal lymphatic transport of lipophilic drugs. J Pharm Sci. 2000;89(8):1073\u201384. https:\/\/doi.org\/10.1002\/1520-6017(200008)89:8%3C1073::AID-JPS11%3E3.0.CO;2-C.","journal-title":"J Pharm Sci"},{"issue":"1","key":"671_CR169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","volume":"116","author":"A Des Rieux","year":"2006","unstructured":"Des Rieux A, Fievez V, Garinot M, Schneider YJ, Pr\u00e9at V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Controlled Release. 2006;116(1):1\u201327. https:\/\/doi.org\/10.1016\/j.jconrel.2006.08.013.","journal-title":"J Controlled Release"},{"issue":"14","key":"671_CR170","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1039\/D1BM00412E","volume":"9","author":"W Zheng","year":"2021","unstructured":"Zheng W, Zhang Y, Chen J. Apolipoprotein B-mimicking lipid-polymer hybrid nanoparticles for targeted intestinal lymphatic transport of peptide therapeutics. Biomaterials Sci. 2021;9(14):4890\u2013902. https:\/\/doi.org\/10.1039\/D1BM00412E.","journal-title":"Biomaterials Sci"},{"key":"671_CR171","doi-asserted-by":"publisher","first-page":"Article891212","DOI":"10.1155\/2015\/891212","volume":"2015","author":"P Fonte","year":"2015","unstructured":"Fonte P, Ara\u00fajo F, Reis S, Sarmento B. Oral insulin delivery: How far are we? J Diabetes Res. 2015;2015:Article891212. https:\/\/doi.org\/10.1155\/2015\/891212.","journal-title":"J Diabetes Res"},{"issue":"1","key":"671_CR172","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijpharm.2017.08.083","volume":"531","author":"CY Wong","year":"2017","unstructured":"Wong CY, Al-Salami H, Dass CR. Microparticles, nanoparticles and colloidal carriers for oral insulin delivery. Int J Pharm. 2017;531(1):217\u201329. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.083.","journal-title":"Int J Pharm"},{"key":"671_CR173","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2015.05.282","volume":"211","author":"J Sheng","year":"2015","unstructured":"Sheng J, Han L, Qin J, Ru G, Li R, Yang L, He H. N-trimethyl chitosan chloride-coated sodium deoxycholate liposomes for oral insulin delivery to improve permeability and absorption. J Controlled Release. 2015;211:102\u201311. https:\/\/doi.org\/10.1016\/j.jconrel.2015.05.282.","journal-title":"J Controlled Release"},{"issue":"22","key":"671_CR174","doi-asserted-by":"publisher","first-page":"19823","DOI":"10.1021\/acsami.9b04212","volume":"11","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Liu D, Chen X, Wang Y. Bile acid-conjugated cubosomes for oral delivery of insulin: Enhanced intestinal transport and therapeutic efficacy in diabetic dogs. ACS Appl Mater Interfaces. 2019;11(22):19823\u201335. https:\/\/doi.org\/10.1021\/acsami.9b04212.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"671_CR175","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.nano.2017.03.001","volume":"13","author":"AK Agrawal","year":"2017","unstructured":"Agrawal AK, Aquil F, Jeyabalan J, Spencer WA, Valencia R, Alvarez MV, Gupta RC. Milk-derived exosomes for oral delivery of paclitaxel and therapeutics. Nanomed Nanotechnol Biol Med. 2017;13(5):1627\u201336. https:\/\/doi.org\/10.1016\/j.nano.2017.03.001.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"6","key":"671_CR176","doi-asserted-by":"publisher","first-page":"E1200","DOI":"10.1152\/ajpendo.00516.2005","volume":"290","author":"DS Edgerton","year":"2006","unstructured":"Edgerton DS, Lautz M, Scott M, Everett CA, Stettler KM, Neal DW, Chu CA, Cherrington AD. Physiological impact of portal versus peripheral insulin delivery in conscious dogs. Am J Physiology-Endocrinology Metabolism. 2006;290(6):E1200\u201310. https:\/\/doi.org\/10.1152\/ajpendo.00516.2005.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"1","key":"671_CR177","doi-asserted-by":"publisher","first-page":"E67","DOI":"10.1152\/ajpendo.00196.2005","volume":"290","author":"HJ Woerle","year":"2006","unstructured":"Woerle HJ, Szoke E, Meyer C, Dostou JM, Wittlin SD, Gosmanov NR, Welle SL, Gerich JE. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am J Physiology-Endocrinology Metabolism. 2006;290(1):E67\u201377. https:\/\/doi.org\/10.1152\/ajpendo.00196.2005.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"1","key":"671_CR178","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0168-3659(00)00378-6","volume":"71","author":"D Stepensky","year":"2001","unstructured":"Stepensky D, Friedman M, Srour W, Raz I, Hoffman A. Preclinical evaluation of pharmacokinetics and pharmacodynamics of metformin extended-release formulations. J Controlled Release. 2001;71(1):107\u201315. https:\/\/doi.org\/10.1016\/s0168-3659(00)00378-6.","journal-title":"J Controlled Release"},{"key":"671_CR179","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.addr.2017.01.006","volume":"116","author":"X Liang","year":"2017","unstructured":"Liang X, Giacomini KM. Transporters involved in metformin pharmacokinetics and pharmacodynamics. Adv Drug Deliv Rev. 2017;116:126\u201341. https:\/\/doi.org\/10.1016\/j.addr.2017.01.006.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"671_CR180","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50(2):81\u201398. https:\/\/doi.org\/10.2165\/11534750-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"key":"671_CR181","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.carbpol.2013.12.034","volume":"103","author":"KS Snima","year":"2014","unstructured":"Snima KS, Jayakumar R, Unnikrishnan AG, Nair SV, Lakshmanan VK. O-carboxymethyl chitosan nanoparticles for metformin delivery to pancreas. Carbohydr Polym. 2014;103:258\u201365. https:\/\/doi.org\/10.1016\/j.carbpol.2013.12.034.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"671_CR182","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2011.04.012","volume":"154","author":"C Maderuelo","year":"2011","unstructured":"Maderuelo C, Zarzuelo A, Lanao JM. Critical factors in the design of gastroretentive dosage forms based on floating systems. J Controlled Release. 2011;154(1):2\u201316. https:\/\/doi.org\/10.1016\/j.jconrel.2011.04.012.","journal-title":"J Controlled Release"},{"issue":"1","key":"671_CR183","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40262-013-0104-3","volume":"53","author":"S Kasichayanula","year":"2014","unstructured":"Kasichayanula S, Liu X, Lacreta F, Griffen SC, Boulton DW. Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter-2. Clin Pharmacokinet. 2014;53(1):17\u201327. https:\/\/doi.org\/10.1007\/s40262-013-0104-3.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"671_CR184","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40262-015-0241-1","volume":"54","author":"AJ Scheen","year":"2015","unstructured":"[ Scheen AJ. Pharmacokinetic and pharmacodynamic profile of empagliflozin, a sodium glucose co-transporter 2 inhibitor. Clin Pharmacokinet. 2015;54(7):693\u2013708. https:\/\/doi.org\/10.1007\/s40262-015-0241-1.","journal-title":"Clin Pharmacokinet"},{"issue":"3 Pt B","key":"671_CR185","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ejpb.2013.09.007","volume":"85","author":"CL Vo","year":"2013","unstructured":"Vo CL, Park C, Lee BJ. Current trends and future perspectives of solid dispersions in oral drug delivery. Eur J Pharm Biopharm. 2013;85(3 Pt B):799\u2013813. https:\/\/doi.org\/10.1016\/j.ejpb.2013.09.007.","journal-title":"Eur J Pharm Biopharm"},{"issue":"23\u201324","key":"671_CR186","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","volume":"12","author":"T Vasconcelos","year":"2007","unstructured":"Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today. 2007;12(23\u201324):1068\u201375. https:\/\/doi.org\/10.1016\/j.drudis.2007.09.005.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"671_CR187","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","volume":"62","author":"CM Keck","year":"2006","unstructured":"Keck CM, M\u00fcller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur J Pharm Biopharm. 2006;62(1):3\u201316. https:\/\/doi.org\/10.1016\/j.ejpb.2005.05.009.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"671_CR188","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","volume":"19","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discovery. 2020;19(4):277\u201389. https:\/\/doi.org\/10.1038\/s41573-019-0053-0.","journal-title":"Nat Rev Drug Discovery"},{"issue":"467","key":"671_CR189","doi-asserted-by":"publisher","first-page":"eaar7047","DOI":"10.1126\/scitranslmed.aar7047","volume":"10","author":"ST Buckley","year":"2018","unstructured":"Buckley ST, B\u00e6kdal TA, Vegge A, Maarbjerg SJ, Pyke C, Ahnfelt-R\u00f8nne J, Madsen KG, Schjellerup IT, Bjerregaard S, Steensgaard DB, Knudsen LB. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci Transl Med. 2018;10(467):eaar7047. https:\/\/doi.org\/10.1126\/scitranslmed.aar7047.","journal-title":"Sci Transl Med"},{"key":"671_CR190","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2019.00155","volume":"10","author":"LB Knudsen","year":"2019","unstructured":"Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol. 2019;10:155. https:\/\/doi.org\/10.3389\/fendo.2019.00155.","journal-title":"Front Endocrinol"},{"issue":"8","key":"671_CR191","doi-asserted-by":"publisher","first-page":"12450","DOI":"10.1021\/acsnano.2c03841","volume":"16","author":"H Zhang","year":"2022","unstructured":"Zhang H, Liu Y, Wang J. Polydopamine-coated metal-organic framework nanoparticles for oral GLP-1 receptor agonist delivery. ACS Nano. 2022;16(8):12450\u201362. https:\/\/doi.org\/10.1021\/acsnano.2c03841.","journal-title":"ACS Nano"},{"key":"671_CR192","doi-asserted-by":"publisher","first-page":"120910","DOI":"10.1016\/j.biomaterials.2021.120910","volume":"275","author":"C Liu","year":"2021","unstructured":"Liu C, Wang X, Zhang Y. Bioinspired gastric-mucoadhesive nanoparticles mimicking Helicobacter pylori for oral exenatide delivery. Biomaterials. 2021;275:120910. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120910.","journal-title":"Biomaterials"},{"issue":"9","key":"671_CR193","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1002\/jps.24222","volume":"104","author":"A Mitra","year":"2015","unstructured":"Mitra A, Kesisoglou F, Dogterom P. Application of physiologically based pharmacokinetic modeling in oral drug delivery. J Pharm Sci. 2015;104(9):2730\u201345. https:\/\/doi.org\/10.1002\/jps.24222.","journal-title":"J Pharm Sci"},{"key":"671_CR194","unstructured":"U.S. Food and Drug Administration. Extended release oral dosage forms: Development, evaluation, and application of in vitro\/in vivo correlations. Guidance for Industry). CDER\/FDA; 1997."},{"issue":"7","key":"671_CR195","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","volume":"25","author":"E Jantratid","year":"2008","unstructured":"Jantratid E, Janssen N, Reppas C, Dressman JB. Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update. Pharm Res. 2008;25(7):1663\u201376. https:\/\/doi.org\/10.1007\/s11095-008-9569-4.","journal-title":"Pharm Res"},{"issue":"1","key":"671_CR196","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijpharm.2013.06.012","volume":"454","author":"A Elgart","year":"2013","unstructured":"Elgart A, Cherniakov I, Aldouby Y, Domb AJ, Hoffman A. Lipophilic prodrug approach for nano-sized carrier systems: IVIVC establishment for oral glibenclamide. Int J Pharm. 2013;454(1):478\u201385. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.06.012.","journal-title":"Int J Pharm"},{"key":"671_CR197","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejps.2013.08.024","volume":"57","author":"ES Kostewicz","year":"2014","unstructured":"Kostewicz ES, Abrahamsson B, Brewster M, Browne J, Bermejo M, Carlsson A, Cetusic JP, Peter AR, Dressman JB. In vitro models for predicting in vivo performance of oral dosage forms. Eur J Pharm Sci. 2014;57:342\u201366. https:\/\/doi.org\/10.1016\/j.ejps.2013.08.024.","journal-title":"Eur J Pharm Sci"},{"key":"671_CR198","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (2009). Pharmaceutical development: Q8(R2) (ICH Harmonised Tripartite Guideline)."},{"issue":"11","key":"671_CR199","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1002\/jps.24912","volume":"106","author":"L Zhang","year":"2017","unstructured":"Zhang L, Mao S. Application of Quality by Design (QbD) in the development of nanoparticle-based drug delivery systems. J Pharm Sci. 2017;106(11):3182\u201391. https:\/\/doi.org\/10.1002\/jps.24912.","journal-title":"J Pharm Sci"},{"key":"671_CR200","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.2147\/IJN.S139882","volume":"12","author":"T Bastogne","year":"2017","unstructured":"Bastogne T. Quality-by-design of nanomedicines: Defining the design space. Int J Nanomed. 2017;12:7103\u201311. https:\/\/doi.org\/10.2147\/IJN.S139882.","journal-title":"Int J Nanomed"},{"issue":"4","key":"671_CR201","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/08982104.2014.911315","volume":"24","author":"B Singh","year":"2014","unstructured":"Singh B, Beg S, Khurana F, Raza K. Formulation optimization of pioglitazone-loaded nanostructured lipid carriers using Box-Behnken design. J Liposome Res. 2014;24(4):299\u2013308. https:\/\/doi.org\/10.3109\/08982104.2014.911315.","journal-title":"J Liposome Res"},{"issue":"1\u20132","key":"671_CR202","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijpharm.2011.07.039","volume":"419","author":"P Barmpalexis","year":"2011","unstructured":"Barmpalexis P, Kanaze FI, Georgarakis E. Artificial neural networks (ANNs) and response surface methodology (RSM) in optimizing PLGA nanoparticle formulations. Int J Pharm. 2011;419(1\u20132):305\u201313. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.07.039.","journal-title":"Int J Pharm"},{"issue":"10","key":"671_CR203","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1517\/17425247.2014.932808","volume":"11","author":"R Paliwal","year":"2014","unstructured":"Paliwal R, Babu RJ, Palakurthi S. Nanomedicine scale-up technologies: Feasibility and economic considerations. Expert Opin Drug Deliv. 2014;11(10):1603\u201316. https:\/\/doi.org\/10.1517\/17425247.2014.932808.","journal-title":"Expert Opin Drug Deliv"},{"issue":"Suppl","key":"671_CR204","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","volume":"64","author":"W Mehnert","year":"2012","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev. 2012;64(Suppl):83\u2013101. https:\/\/doi.org\/10.1016\/j.addr.2012.09.021.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"671_CR205","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nnano.2012.168","volume":"7","author":"PM Valencia","year":"2012","unstructured":"Valencia PM, Farokhzad OC, Karnik R, Langer R. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol. 2012;7(10):623\u20139. https:\/\/doi.org\/10.1038\/nnano.2012.168.","journal-title":"Nat Nanotechnol"},{"key":"671_CR206","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2014.10.020","volume":"84","author":"A Sosnik","year":"2015","unstructured":"Sosnik A, Seremeta KP. Advantages and challenges of the spray-drying technology for the production of pure drug nanoparticles and nano-structured particles. Adv Drug Deliv Rev. 2015;84:158\u201379. https:\/\/doi.org\/10.1016\/j.addr.2014.10.020.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"671_CR207","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijpharm.2010.10.014","volume":"403","author":"D Heng","year":"2011","unstructured":"Heng D, Lee SH, Ng WK, Tan RB. Nano-spray drying: A novel method for preparing protein nanoparticles for drug delivery. Int J Pharm. 2011;403(1\u20132):192\u2013200. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.10.014.","journal-title":"Int J Pharm"},{"issue":"1","key":"671_CR208","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijpharm.2012.11.001","volume":"453","author":"S Shah","year":"2013","unstructured":"Shah S, Maddineni S, Lu J, Repka MA. Melt extrusion with poorly soluble drugs. Int J Pharm. 2013;453(1):233\u201352. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.11.001.","journal-title":"Int J Pharm"},{"issue":"6478","key":"671_CR209","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"key":"671_CR210","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jconrel.2020.07.037","volume":"326","author":"G Liang","year":"2020","unstructured":"Liang G, Zhu Y, Sun B, Hu F, Le T, Chen A, Li X, Zhang Y. Extracellular vesicles for targeted peptide and protein delivery. J Controlled Release. 2020;326:455\u201366. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.037.","journal-title":"J Controlled Release"},{"issue":"5","key":"671_CR211","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chom.2018.10.001","volume":"24","author":"Y Teng","year":"2018","unstructured":"Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A, Zhang L, Wang Q. Plant-derived exosomal nanoparticles inhibit inflammatory bowel disease. Cell Host Microbe. 2018;24(5):637\u201352. https:\/\/doi.org\/10.1016\/j.chom.2018.10.001.","journal-title":"Cell Host Microbe"},{"key":"671_CR212","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.biomaterials.2016.06.018","volume":"101","author":"M Zhang","year":"2016","unstructured":"Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, Merlin D. Edible ginger-derived nanoparticles: A novel therapeutic approach for inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016;101:321\u201340. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.06.018.","journal-title":"Biomaterials"},{"issue":"2","key":"671_CR213","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/ijn.s596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong WH, Borm PJ. Drug delivery and nanoparticles: Applications and hazards. Int J Nanomed. 2008;3(2):133\u201349. https:\/\/doi.org\/10.2147\/ijn.s596.","journal-title":"Int J Nanomed"},{"issue":"5761","key":"671_CR214","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.1114397","volume":"311","author":"A Nel","year":"2006","unstructured":"Nel A, Xia T, M\u00e4dler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622\u20137. https:\/\/doi.org\/10.1126\/science.1114397.","journal-title":"Science"},{"issue":"2","key":"671_CR215","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: An overview of biomedical applications. J Controlled Release. 2012;161(2):505\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.043.","journal-title":"J Controlled Release"},{"key":"671_CR216","doi-asserted-by":"publisher","first-page":"104951","DOI":"10.1016\/j.tiv.2020.104951","volume":"68","author":"X Chen","year":"2020","unstructured":"Chen X, Wang Y, Zhou Z. Cytotoxicity and zinc ion release kinetics of ZIF-8 metal-organic frameworks in intestinal epithelial cell lines. Toxicol In Vitro. 2020;68:104951. https:\/\/doi.org\/10.1016\/j.tiv.2020.104951.","journal-title":"Toxicol In Vitro"},{"key":"671_CR217","doi-asserted-by":"publisher","unstructured":"Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academies; 2001. https:\/\/doi.org\/10.17226\/10026.","DOI":"10.17226\/10026"},{"key":"671_CR218","unstructured":"European Medicines Agency. (2013). Reflection paper on surface effects for intravenous nanomedicine products (EMA\/CHMP\/SWP\/686140\/2012). Committee for Medicinal Products for Human Use."},{"issue":"2\u20133","key":"671_CR219","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s0278-6915(01)00118-1","volume":"40","author":"G Eisenbrand","year":"2002","unstructured":"Eisenbrand G, Pool-Zobel B, Baker V, Balls M, Blaauboer BJ, Boobis A, Carere A, Kevekordes S, Lhuguenot JC, Pieters R, Kleiner J. Methods of in vitro toxicology. Food Chem Toxicol. 2002;40(2\u20133):193\u2013236. https:\/\/doi.org\/10.1016\/s0278-6915(01)00118-1.","journal-title":"Food Chem Toxicol"},{"key":"671_CR220","unstructured":"Organisation for Economic Co-operation and Development. Test No. 407: Repeated dose 28-day oral toxicity study in rodents. OECD Guidelines for the Testing of Chemicals; 2018."},{"key":"671_CR221","unstructured":"U.S. Food and Drug Administration. Human gene therapy products incorporating human genome editing. Draft Guidance for Industry. Center for Biologics Evaluation and Research; 2022."},{"issue":"45","key":"671_CR222","doi-asserted-by":"publisher","first-page":"19787","DOI":"10.1002\/anie.202011449","volume":"59","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Tang Z, Wang J, Liu C, Zhang Y. Oral insulin delivery platforms: Strategies to address the biological barriers. Angew Chem Int Ed. 2020;59(45):19787\u201395. https:\/\/doi.org\/10.1002\/anie.202011449.","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"671_CR223","doi-asserted-by":"publisher","first-page":"103393","DOI":"10.1016\/j.drudis.2022.103393","volume":"28","author":"L Pang","year":"2023","unstructured":"Pang L, Eilleia A, Zhang H. Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes. Drug Discovery Today. 2023;28(1):103393. https:\/\/doi.org\/10.1016\/j.drudis.2022.103393.","journal-title":"Drug Discovery Today"},{"issue":"21","key":"671_CR224","doi-asserted-by":"publisher","first-page":"24321","DOI":"10.1021\/acsami.1c03562","volume":"13","author":"S Chen","year":"2021","unstructured":"Chen S, Wang L, Zhao Y. Glucose-responsive hydrogels and nanocarriers for self-regulated insulin delivery. ACS Appl Mater Interfaces. 2021;13(21):24321\u201335. https:\/\/doi.org\/10.1021\/acsami.1c03562.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"671_CR225","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1021\/acs.biomac.1c01542","volume":"23","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang X, Wang J. pH and redox dual-responsive polymeric nanoparticles for colon-targeted delivery of antidiabetic peptides. Biomacromolecules. 2022;23(4):1678\u201389. https:\/\/doi.org\/10.1021\/acs.biomac.1c01542.","journal-title":"Biomacromolecules"},{"issue":"1","key":"671_CR226","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1021\/bm0607776","volume":"8","author":"YH Lin","year":"2007","unstructured":"Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, Sung HW. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules. 2007;8(1):146\u201352. https:\/\/doi.org\/10.1021\/bm0607776.","journal-title":"Biomacromolecules"},{"issue":"213","key":"671_CR227","doi-asserted-by":"publisher","first-page":"213ra167","DOI":"10.1126\/scitranslmed.3007049","volume":"5","author":"EM Pridgen","year":"2013","unstructured":"Pridgen EM, Alexis F, Kuo TT, Levy-Nissenbaum E, Karnik R, Blumberg RS, Langer R, Farokhzad OC. Transepithelial transport of Fc-targeted nanoparticles across the intestinal mucosa. Sci Transl Med. 2013;5(213):213ra167. https:\/\/doi.org\/10.1126\/scitranslmed.3007049.","journal-title":"Sci Transl Med"},{"issue":"8","key":"671_CR228","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","volume":"59","author":"LM Bareford","year":"2007","unstructured":"Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev. 2007;59(8):748\u201358. https:\/\/doi.org\/10.1016\/j.addr.2007.06.008.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"671_CR229","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2):158\u201371. https:\/\/doi.org\/10.1016\/j.addr.2008.11.002.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"671_CR230","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/nn506290w","volume":"9","author":"W Shan","year":"2015","unstructured":"Shan W, Zhu X, Liu M, Tao W, Guo Z, Sun Y, Huang Y. Overcoming the intestinal mucosal barrier by counter-charged amphiphilic nanoparticles for oral insulin delivery. ACS Nano. 2015;9(3):2345\u201356. https:\/\/doi.org\/10.1021\/nn506290w.","journal-title":"ACS Nano"},{"issue":"5","key":"671_CR231","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.drudis.2018.01.033","volume":"23","author":"A Bernkop-Schn\u00fcrch","year":"2018","unstructured":"Bernkop-Schn\u00fcrch A. Mucoadhesive systems in oral drug delivery. Drug Discovery Today. 2018;23(5):1055\u201362. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.033.","journal-title":"Drug Discovery Today"},{"key":"671_CR232","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.addr.2016.04.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277\u2013319. https:\/\/doi.org\/10.1016\/j.addr.2016.04.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"671_CR233","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/pharmaceutics11020078","volume":"11","author":"C Twarog","year":"2019","unstructured":"Twarog C, Fattah S, Heade J, Maher S, Fattal E, Brayden DJ. Intestinal permeation enhancers for oral delivery of macromolecules: A comparison between medium chain fatty acids and SNAC. Pharmaceutics. 2019;11(2):78. https:\/\/doi.org\/10.3390\/pharmaceutics11020078.","journal-title":"Pharmaceutics"},{"issue":"4","key":"671_CR234","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.addr.2003.10.030","volume":"56","author":"C Bies","year":"2004","unstructured":"Bies C, Lehr CM, Woodley JF. Lectin-mediated drug targeting: History and applications. Adv Drug Deliv Rev. 2004;56(4):425\u201335. https:\/\/doi.org\/10.1016\/j.addr.2003.10.030.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"671_CR235","doi-asserted-by":"publisher","first-page":"e10143","DOI":"10.1002\/btm2.10143","volume":"4","author":"AC Anselmo","year":"2019","unstructured":"Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update. Bioeng Translational Med. 2019;4(3):e10143. https:\/\/doi.org\/10.1002\/btm2.10143.","journal-title":"Bioeng Translational Med"},{"key":"671_CR236","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fphar.2018.00790","volume":"9","author":"S Hua","year":"2018","unstructured":"Hua S, de Matos MB, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines. Front Pharmacol. 2018;9:790. https:\/\/doi.org\/10.3389\/fphar.2018.00790.","journal-title":"Front Pharmacol"},{"issue":"10","key":"671_CR237","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","volume":"326","author":"M Germain","year":"2020","unstructured":"Germain M, Caputo F, Metcalfe S, Tosi G, Spring K, \u00c5slund AKO, Pottier A, Schiffelers R, Ceccaldi A, Schmid R. Delivering the power of nanomedicine to patients today. J Controlled Release. 2020;326(10):164\u201371. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.007.","journal-title":"J Controlled Release"},{"issue":"12","key":"671_CR238","first-page":"742","volume":"42","author":"CL Ventola","year":"2017","unstructured":"Ventola CL. Progress in nanomedicine: Approved and investigational nanodrugs. Pharm Ther. 2017;42(12):742\u201355.","journal-title":"Pharm Ther"},{"issue":"1","key":"671_CR239","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40005-017-0370-4","volume":"48","author":"YH Choi","year":"2018","unstructured":"Choi YH, Han HK. Nanomedicines: Current status and future perspectives in oral delivery of lipophilic drugs. J Pharm Invest. 2018;48(1):43\u201360. https:\/\/doi.org\/10.1007\/s40005-017-0370-4.","journal-title":"J Pharm Invest"},{"key":"671_CR240","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fchem.2018.00360","volume":"6","author":"S Soares","year":"2018","unstructured":"Soares S, Sousa J, Pais A, Vitorino C. Nanomedicine: Principles, properties, and regulatory issues. Front Chem. 2018;6:360. https:\/\/doi.org\/10.3389\/fchem.2018.00360.","journal-title":"Front Chem"},{"key":"671_CR241","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.biomaterials.2015.04.018","volume":"57","author":"V Sainz","year":"2015","unstructured":"Sainz V, Conniot J, Matos AI, Carreira B, Sesardic D, Rego de Figueiredo IR, Florindo HF. Regulatory aspects for nanomedicines. Biomaterials. 2015;57:120\u201333. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.04.018.","journal-title":"Biomaterials"},{"issue":"3","key":"671_CR242","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-w","volume":"12","author":"S \u0110or\u0111evi\u0107","year":"2022","unstructured":"\u0110or\u0111evi\u0107 S, Gonzalez MM, Conejos-S\u00e1nchez I, Carreira B, Pozzi S, Ac\u00farcio RC, Satchi-Fainaro R, Florindo HF, Vicent MJ. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Delivery Translational Res. 2022;12(3):500\u201325. https:\/\/doi.org\/10.1007\/s13346-021-01024-w.","journal-title":"Drug Delivery Translational Res"},{"key":"671_CR243","doi-asserted-by":"publisher","unstructured":"Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora LK. Nanoparticle therapeutics in clinical perspective: Classification, marketed products, and regulatory landscape. Small. 2025;21(29). https:\/\/doi.org\/10.1002\/smll.202502315.","DOI":"10.1002\/smll.202502315"},{"key":"671_CR244","doi-asserted-by":"publisher","unstructured":"Stucchi F, Wooley KL. Regulatory framework for polymer-based nanotherapeutics in clinical translation. Front Bioeng Biotechnol. 2026;14., Article 1735885. https:\/\/doi.org\/10.3389\/fbioe.2026.1735885.","DOI":"10.3389\/fbioe.2026.1735885"},{"issue":"8","key":"671_CR245","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/17435889.2026.2645781","volume":"21","author":"N Kushwaha","year":"2026","unstructured":"Kushwaha N, Patel A, Akarte K. Process and purification synergies with data analytics driving clinical translation in nanomedicine. Nanomedicine. 2026;21(8):1195\u2013222. https:\/\/doi.org\/10.1080\/17435889.2026.2645781.","journal-title":"Nanomedicine"},{"key":"671_CR246","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.2147\/IJN.S2026.06","volume":"21","author":"SM Fayez","year":"2026","unstructured":"Fayez SM. Nanomedicine in 2026: Illustrative quantitative analyses of EPR heterogeneity, clinical trial attrition, and emerging horizons for active nanotherapeutics. Int J Nanomed. 2026;21:3105\u201324. https:\/\/doi.org\/10.2147\/IJN.S2026.06.","journal-title":"Int J Nanomed"},{"issue":"6","key":"671_CR247","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10989-025-10763-6","volume":"31","author":"SJ Cao","year":"2025","unstructured":"Cao SJ, Xu S, Wang HM, Ling Y, Dong S, Li Y. Oral delivery of macromolecular drugs: Advances in nanoformulation design and computational optimization. Int J Pept Res Ther. 2025;31(6):101. https:\/\/doi.org\/10.1007\/s10989-025-10763-6.","journal-title":"Int J Pept Res Ther"},{"key":"671_CR248","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2025.01.018","volume":"378","author":"G Chen","year":"2025","unstructured":"Chen G, Zhang Y, Wang L. Advances in the oral delivery of protein and peptide drugs: Molecular barriers, intestinal permeation enhancers, and nanocarrier design. J Controlled Release. 2025;378:215\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.018.","journal-title":"J Controlled Release"},{"key":"671_CR249","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2147\/IJN.S529791","volume":"20","author":"Y Wang","year":"2025","unstructured":"Wang Y, Liu H, Zhao X. Cell-penetrating peptide-functionalized nanocarriers for oral insulin delivery: Mechanisms, transport pathways, and translational potential. Int J Nanomed. 2025;20:1415\u201332. https:\/\/doi.org\/10.2147\/IJN.S529791.","journal-title":"Int J Nanomed"},{"key":"671_CR250","doi-asserted-by":"publisher","first-page":"115210","DOI":"10.1016\/j.addr.2025.115210","volume":"208","author":"TM Allen","year":"2025","unstructured":"Allen TM, Cullis PR. Liposomal and lipid nanoparticle-based oral delivery systems: From biophysical foundations to clinical realities. Adv Drug Deliv Rev. 2025;208:115210. https:\/\/doi.org\/10.1016\/j.addr.2025.115210.","journal-title":"Adv Drug Deliv Rev"},{"key":"671_CR251","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.2147\/IJN.S2026.06","volume":"21","author":"SM Fayez","year":"2026","unstructured":"Fayez SM. Nanomedicine in 2026: Illustrative quantitative analyses of EPR heterogeneity, clinical trial attrition, and emerging horizons for active nanotherapeutics. Int J Nanomed. 2026;21:3105\u201324. https:\/\/doi.org\/10.2147\/IJN.S2026.06.","journal-title":"Int J Nanomed"},{"issue":"2","key":"671_CR252","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41573-025-00982-x","volume":"25","author":"MJ Mitchell","year":"2026","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision oral nanomedicines for metabolic and endocrine diseases. Nat Rev Drug Discovery. 2026;25(2):112\u201335. https:\/\/doi.org\/10.1038\/s41573-025-00982-x.","journal-title":"Nat Rev Drug Discovery"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00671-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:06:46Z","timestamp":1791238006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00671-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":253,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["671"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00671-5","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"89"}}